The World Health Organization, WHO, does not believe the monkeypox outbreak outside of Africa requires mass vaccinations as measures like good hygiene and safe sexual behaviour will help control its spread, a senior official said on Monday.
Richard Pebody, who leads the high-threat pathogen team at WHO Europe, that immediate supplies of vaccines and antivirals are relatively limited.
His comments came as the U.S. Centers for Disease Control and Prevention said it was in the process of releasing some Jynneos vaccine doses for use in monkeypox cases.
Germany’s government said on Monday that it was assessing options for vaccinations, while Britain has offered them to some healthcare workers.
Public health authorities in Europe and North America are investigating more than 100 suspected and confirmed cases of the viral infection in the worst outbreak of the virus outside of Africa, where it is endemic.
The primary measures to control the outbreak are contact tracing and isolation, Pebody said, noting that it is not a virus that spreads very easily, nor has it so far caused serious disease. He added that the vaccines used to combat monkeypox could have some significant side effects.
It is unclear what is driving the outbreak, with scientists trying to understand the origin of the cases and whether anything about the virus has changed. There is no evidence that the virus has mutated, a senior executive at the U.N. agency said separately.
Many – but not all – of the people who have been diagnosed in the current monkeypox outbreak have been men who have sex with men. But that may be because this demographic is likely to seek medical advice or access sexual health screening more readily, the WHO said earlier.
Most of the confirmed cases have not been linked to travel to Africa, which suggests there may be many undetected cases, said Pebody. Some health authorities suspect there is some degree of community spread.
